Myriad Genetics (MYGN) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $4.32 -6.7%
EPS Growth %: -220.0%
Financial Fact:
Income from continuing operations before income taxes: 4M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -220.0%
Financial Fact:
Income from continuing operations before income taxes: 4M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q2 EPS of $0.45, $0.04 better than the analyst estimate of $0.41. Revenue for the quarter came in at $193.3 million versus the consensus estimate of $189.97 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- RH (RH) Tops Q1 EPS by 12c
- Aspire Biopharma to acquire automotive supplier for $30 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
